Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Genitourinary 2Thoracic 1Gynecologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Breast Neoplasms 19Lung Neoplasms 11Stomach Neoplasms 9Colorectal Neoplasms 9Pancreatic Neoplasms 8Endometrial Neoplasms 8Ovarian Neoplasms 7Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Neoplasms 5Neoplasm Metastasis 5Esophageal Neoplasms 5Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Breast Neoplasms, Male 4Thyroid Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Melanoma 3Gallbladder Neoplasms 3Colonic Neoplasms 3Carcinoma, Ovarian Epithelial 3Vulvar Neoplasms 2Vipoma 2Vaginal Neoplasms 2Uterine Neoplasms 2

Interventions

pembrolizumab 6Nivolumab 3Gemcitabine 3Cisplatin 3Carboplatin 3brigimadlin 2Ramucirumab 2Fluorouracil 2Docetaxel 2Cetuximab 2tucatinib 1trifluridine tipiracil drug combination 1tremelimumab 1trametinib 1regorafenib 1pertuzumab 1milademetan 1larotrectinib 1futibatinib 1durvalumab 1cemiplimab 1adagrasib 1Trastuzumab 1TAS-116 1Ritonavir 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Omacor 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Trastuzumab × Thoracic × Clear all
NCT04579380 2025-12-19

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Seagen Inc.

Phase 2 Active not recruiting
217 enrolled 19 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡